| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 2.1 MB | Adobe PDF |
Orientador(es)
Resumo(s)
Next-generation sequencing is essential in clinical genetics, and Oxford Nanopore technology offers advantages such as portability, rapid analysis, and potential for use outside traditional laboratory environments. This work aimed to evaluate the implementation of the MinION MK1D, operated with a standard laptop, to analyze patients with a targeted 72-gene panel related to monogenic diabetes, using adaptive sampling. Sixteen samples were sequenced, and performance was assessed based on coverage depth and downstream bioinformatic analysis. All samples produced data across the target regions, with an average depth of 2–3×, which limited reliable variant calling. However, interpretable results were still obtained, indicating that with further optimization—such as improved workflow design and enhanced computational resources—Nanopore sequencing could become suitable for decentralized and on-site clinical genetic testing
Descrição
Palavras-chave
Nanopore Sequencing Adaptive Sampling Clinical Genetics Rare Diseases Diagnostic Technologies Genómica Funcional e Estrutural Doenças Genéticas
